Patent directory · USPTO A61K / A61P
Patents matching “The United States of America”
3,063 pharma patents match "The United States of America" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 3,063 pharmaceutical patents matching "The United States of America" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 7311916
Methods of eliciting broadly neutralizing antibodies targeting HIV-1 gp41
granted -
US 7312228
Cytotoxic indeno and isoindoloisoquinolones
granted -
US 7306806
Recombinant P. falciparum merozoite protein-142 vaccine
granted -
US 7303751
Anti-plasmodium compositions and methods of use
granted -
US 7303754
MVA expressing modified HIV envelope, gag, and pol genes
granted -
US 7300940
Integrin α-v β-3 antagonists for use in imaging and therapy
granted -
US 7288254
Use of immunotoxins to induce immune tolerance to pancreatic islet transplantation
granted -
US 7282205
Anti-hepatitis A virus antibodies
granted -
US 7282206
Treatment of fibrosis by antagonism of IL-13 and IL-13 receptor chains
granted -
US 7279163
Water-in-oil emulsion vaccines
granted -
US 7279294
Tumor markers in ovarian cancer
granted -
US 7271150
Modified growth hormone
granted -
US 7267941
Cyanovirin variant-polymer conjugates
granted -
US 7267823
Ebola peptides and immunogenic compositions containing same
granted -
US 7264947
Activity dependent neurotrophic factor III (ADNF III)
granted -
US 7265215
DNA or RNA encoding a recombinant dengue envelope protein
granted -
US 7262027
Polypeptide and DNA immunization against Coccidioides spp. infections
granted -
US 7261896
Methods for preventing strokes by inducing tolerance to e-selectin
granted -
US 7261900
Recombinant modified Bacillus anthracis protective antigen for use in vaccines
granted -
US 7258863
Heterologous protection induced by immunization with invaplex vaccine
granted -
US 7259167
Antimalarial and antiproliferative pharmacophore models, novel tryptanthrin compounds having increased solubility, and methods of making and using thereof
granted -
US 7259142
Redox-stable, non-phosphorylated cyclic peptide inhibitors of SH2 domain binding to target protein, conjugates thereof, compositions and methods of synthesis and use
granted -
US 7258859
Method for the treatment of multiple sclerosis
granted -
US 7256260
Human p53 mutations and a genetic system in yeast for functional identification of human p53 mutations
granted